As of 2024-12-12, the Relative Valuation of Regeneron Pharmaceuticals Inc (REGN) is 630.34 USD. This relative valuation is based on P/E multiples. With the latest stock price at 773.00 USD, the upside of Regeneron Pharmaceuticals Inc based on Relative Valuation is -18.5%.
The range of the Relative Valuation is 581.02 - 652.70 USD.
| Range | Selected | |
| Trailing P/E multiples | 15.0x - 15.4x | 15.2x |
| Forward P/E multiples | 15.4x - 17.3x | 16.4x |
| Fair Price | 581.02 - 652.70 | 630.34 |
| Upside | -24.8% - -15.6% | -18.5% |
| Date | P/E |
| 2024-12-12 | 17.97 |
| 2024-12-11 | 18.25 |
| 2024-12-10 | 18.38 |
| 2024-12-09 | 18.60 |
| 2024-12-06 | 18.37 |
| 2024-12-05 | 18.13 |
| 2024-12-04 | 17.81 |
| 2024-12-03 | 17.70 |
| 2024-12-02 | 18.00 |
| 2024-11-29 | 17.71 |
| 2024-11-27 | 17.82 |
| 2024-11-26 | 17.78 |
| 2024-11-25 | 17.70 |
| 2024-11-22 | 17.42 |
| 2024-11-21 | 17.58 |
| 2024-11-20 | 17.55 |
| 2024-11-19 | 17.58 |
| 2024-11-18 | 17.99 |
| 2024-11-15 | 17.87 |
| 2024-11-14 | 18.47 |
| 2024-11-13 | 18.99 |
| 2024-11-12 | 19.38 |
| 2024-11-11 | 19.49 |
| 2024-11-08 | 19.56 |
| 2024-11-07 | 19.47 |
| 2024-11-06 | 19.28 |
| 2024-11-05 | 19.58 |
| 2024-11-04 | 19.57 |
| 2024-11-01 | 19.92 |
| 2024-10-31 | 19.79 |
| 2024-10-30 | 21.79 |
| 2024-10-29 | 21.89 |
| 2024-10-28 | 21.92 |
| 2024-10-25 | 22.03 |
| 2024-10-24 | 21.93 |
| 2024-10-23 | 22.23 |
| 2024-10-22 | 22.72 |
| 2024-10-21 | 22.87 |
| 2024-10-18 | 23.39 |
| 2024-10-17 | 23.57 |
| 2024-10-16 | 23.80 |
| 2024-10-15 | 24.00 |
| 2024-10-14 | 23.95 |
| 2024-10-11 | 23.98 |
| 2024-10-10 | 23.59 |
| 2024-10-09 | 23.90 |
| 2024-10-08 | 23.73 |
| 2024-10-07 | 23.52 |
| 2024-10-04 | 23.91 |
| 2024-10-03 | 23.95 |